Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Active not recruiting × Neoplasms × Sodium Chloride × Clear all

Phase

Status

Completed 4 Unknown 2 Terminated 2 Recruiting 2 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Small Cell Lung Carcinoma 1 Parkinson Disease 4, Autosomal Dominant Lewy Body 1 Papillomavirus Infections 1 Neoplasms 1 Neoplasm, Residual 1 Leukemia, Hairy Cell 1 Hemorrhage 1 Gliosarcoma 1 Glioblastoma 1 Colorectal Neoplasms 1

Interventions

pembrolizumab 27 Cyclophosphamide 17 Nivolumab 16 fludarabine 8 Surveys and Questionnaires 8 Paclitaxel 8 Exercise 8 Doxorubicin 8 Carboplatin 8 Bevacizumab 8 budigalimab 7 atezolizumab 7 Radiotherapy 7 Fluorouracil 7 Docetaxel 7 Dexamethasone 7 Blood Specimen Collection 7 venetoclax 6 lenvatinib 6 cabozantinib 6 Rituximab 6 Prednisone 6 Pemetrexed 6 Oxaliplatin 6 Gemcitabine 6 fludarabine phosphate 5 durvalumab 5 avelumab 5 Vincristine 5 Leucovorin 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02261415 2022-10-26

HeLiX

Sunnybrook Health Sciences Centre

Phase 3 Active not recruiting

Hemorrhage, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡